Generic Prescription Drugs - Your Health. Our Commitment. #Take with Confidence

NAFTA 2.0: Obstacles to More Affordable Medicines

The U.S.-Mexico-Canada Agreement (USMCA) or "NAFTA 2.0" contains obstacles to more affordable meds for Americans. There is still time to #FixUSMCA to put America’s patient first!

View Infographic
Failure to Launch

Although 20 biosimilars have been approved by the FDA in the U.S., only seven are currently commercially available. Learn how patent abuse blocks access to biosimilars for America's patients.

Read White Paper
American Patients: Tell Congress to Fix the USMCA

AAM’s Jonathan Kimball urges Americans to tell their member of Congress to stand up for patients and fix the USMCA trade agreement (NAFTA 2.0).

View Video
AAM Membership

AAM members gain invaluable access to resources, advocacy support and industry meetings and conferences.

Learn More
Join Me + Get Informed

Don't miss the keynote speaker at GRx+Biosims 2019, former commissioner of the U.S. Food and Drug Administration, Scott Gottlieb, M.D.

Register Now
Generic Drugs: Take with Confidence

According to the FDA, “Generic medications are just as safe and effective as their brand-name counterparts, and often cost less.”

Learn More
AAM's 2019 Access & Savings in the U.S. Report

The quality and affordability of generic medicines makes possible greater access, adherence and improved health for millions of patients across the United States.

Read Report

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Policy

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Video

Jul 19, 2019 | Erica Klinger

AAM's Ashlee Koonce Shares New Exhibitor Opportunities at GRx+Biosims 2019

Video

Jul 19, 2019 | Erica Klinger

Dive Deeper into the Science and Regulatory Track at GRx+Biosims 2019

Video

Jul 19, 2019 | Erica Klinger

AAM's Christine Simmon Talks About Biosimilar Programming at GRx+Biosims 2019

Jul 11, 2019 | Jonathan Kimball

The House Has Spoken – It’s Time to Fix USMCA’s Pharmaceutical Provisions

Jul 2, 2019 | Rachel Schwartz

National Survey Finds Significant Voter Opposition to Patent Settlement Legislation

Biosimilars

Jun 26, 2019 | Rachel Schwartz

AAM Applauds Sens. Cornyn and Blumenthal’s Efforts to Accelerate Access to More Affordable Biosimilar Medicines